Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE)

Historical Holders from Q4 2019 to Q4 2024

Symbol
APRE on Nasdaq
Type / Class
Equity / Common stock, par value $0.001 per share
Shares outstanding
5,434,244
All holders as of 31 Dec 2024
Q4 2024
Total 13F shares, excl. options
0
Holdings value
$0
Number of holders
0
Number of sells
-1
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
HIRSCHMAN ORIN 9.9% $269,650 539,300 Orin Hirschman 31 Dec 2024
Sio Capital Management, LLC 5.09% $138,302 276,603 Sio Capital Management, LLC 31 Dec 2024

Institutional Holders of Aprea Therapeutics, Inc. - Common stock, par value $0.001 per share (APRE)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q4 0 $0 -$2,000 0
2024 Q3 899 $2,000 $2.22 1
2024 Q2 899 $3,000 -$669 $3.34 1
2024 Q1 999 $6,669 +$6,000 $6.68 2
2023 Q4 100 $470 $4.7 1
2023 Q3 100 $417 $4.17 1
2023 Q2 100 $315 -$13 $3.15 1
2023 Q1 103 $457 -$520,123 $4.39 2
2022 Q4 1,587,074 $520,280 -$37,678 $0.331 23
2022 Q3 1,704,277 $1,109,338 -$364,998 $0.6508 23
2022 Q2 2,029,597 $1,519,025 -$805,646 $0.7498 29
2022 Q1 2,418,438 $4,501,000 -$2,768,395 $1.86 38
2021 Q4 3,610,494 $10,361,000 -$8,428,012 $2.87 35
2021 Q3 4,999,711 $25,549,281 -$7,565,851 $5.11 37
2021 Q2 6,538,488 $31,906,000 -$12,001,808 $4.88 48
2021 Q1 8,932,107 $45,408,770 -$6,611,636 $5.1 64
2020 Q4 10,317,198 $50,763,750 -$96,371,442 $4.92 63
2020 Q3 16,834,877 $404,988,700 +$5,638,022 $24.06 65
2020 Q2 16,477,324 $638,906,382 +$117,351,300 $38.78 64
2020 Q1 13,469,861 $467,365,016 +$18,770,937 $34.76 50
2019 Q4 12,931,705 $591,290,000 +$460,153,003 $45.89 39